logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
M

Michał Jarząb

breast cancer center

30H指数
218论文数
2.9K被引数
收录论文 55
发表时间
logo
[18F]FDG PET/CT imaging of the metabolic response in advanced breast cancer patients treated with cyclin-dependent kinase 4/6 inhibitors[18F]FDG PET/CT成像评估接受细胞周期依赖性激酶4/6抑制剂治疗的晚期乳腺癌患者的代谢反应
errBreast Cancer Research
IF5.6
err2026-09-16
err0
errOAAI
errMarcin Kubeczko; Francisco Oliveira; Cláudia Constantino; Joana Castanheira; Helena Gouveia; Leonor Matos; Marcio Debiasi; Michal Jarzab; Durval Costa; Fatima Cardoso; Berta Sousa
err分享
err收藏
Deciphering the role of Ki67: prognostic insights in advanced breast cancer therapy with Cyclin-dependent kinase 4/6 inhibitors解析Ki67的作用：在CDK4/6抑制剂治疗晚期乳腺癌中的预后启示
errBMC Cancer
IF3.4
err2026-02-13
err0
errOAAI
errMarcin Kubeczko; Anna Polakiewicz-Gilowska; Katarzyna Świderska; Marta Mianowska-Malec; Aleksandra Leśniak; Barbarba Łanoszka; Konstanty Chomik; Barbara Grandys; Natalya Lisovska; Grzegorz Woźniak; Tomasz Latusek; Ewa Stobiecka; Jakub Simek; Bartłomiej Pyciński; Barbara Bobek-Billewicz; Ewa Chmielik; Michał Jarząb
err分享
err收藏
Real-world outcomes of sacituzumab govitecan in patients with pretreated triple-negative breast cancer and brain metastases: data from CEBCC-102 studysacituzumab govitecan在预先治疗的三阴性乳腺癌和脑转移患者中的真实结果: 来自CEBCC-102研究的数据
errJournal of Neuro-Oncology
IF3.1
err2026-01-14
err0
PREAI
errJustyna Żubrowska; Małgorzata Pieniążek; Anna Polakiewicz-Gilowska; Iveta Kolářová; Miroslava Malejčíková; Lenka Rušinová; Miloš Holánek; Renáta Soumarová; Karolina Winsko-Szczęsnowicz; Aleksandra Konieczna; Agnieszka Młodzińska; Daniel Krejčí; Iwona Danielewicz; Magdalena Szymanik-Resko; Tomasz Ciszewski; Maja Lisik-Habib; Anika Pękala; Hana Študentová; Jan Šustr; Agnieszka Rudzińska; Marcin Kubeczko; Bogumiła Czartoryska-Arłukowicz; Jolanta Smok-Kalwat; Aleksandra Łacko; Michał Jarząb; Renata Pacholczak-Madej; Zuzana Bielčiková; Mirosława Püsküllüoğlu
err分享
err收藏
Reluctance to Use a Psycho-Oncology Mobile App Among Patients With Primary Breast Cancer: Retrospective Cross-Sectional Survey乳腺癌患者使用肿瘤心理护理移动应用程序的抵触情绪：回顾性横断面调查
errJMIR mHealth and uHealth
IF6.2
err2026-01-01
err0
PREAI
errPawelczak-Szastok, Marta; Syska-Bielak, Anna; Krzywon, Aleksandra; Jarzab, Michal
err分享
err收藏
Prognostic value of baseline FDG PET/CT in HER2-positive metastatic breast cancer treated with first-line trastuzumab, pertuzumab, and docetaxel基线FDG PET/CT对接受一线曲妥珠单抗、帕妥珠单抗和多西他赛治疗的HER2阳性转移性乳腺癌的预后价值
errBreast Cancer Research
IF5.6
err2025-12-10
err0
errOAAI
errMarcin Kubeczko; Andrea d’Amico; Olgierd Chrabanski; Daria Handkiewicz-Junak; Anna Polakiewicz-Gilowska; Katarzyna Swiderska; Marta Mianowska-Malec; Aleksandra Lesniak; Barbarba Lanoszka; Natalya Lisovska; Damian Borys; Bartlomiej Pycinski; Ewa Chmielik; Slawomir Blamek; Aleix Prat; Michal Jarzab
err分享
err收藏
Sacituzumab Govitecan initial dose reduction in polish patients with metastatic triple-negative breast cancer: impact on efficacy and safetySacituzumab Govitecan在波兰转移性三阴性乳腺癌患者中的初始剂量降低：对疗效和安全性的影响
errCancer Chemotherapy and Pharmacology
IF2.3
err2025-10-04
err0
errOAAI
errMałgorzata Pieniążek; Marcin Kubeczko; Manuela Las-Jankowska; Anna Polakiewicz-Gilowska; Aleksandra Łacko; Michał Jarząb; Zuzana Bielčiková; Renata Pacholczak-Madej; Miroslawa Püsküllüoğlu
err分享
err收藏
Strategies for premedication and G-CSF application in sacituzumab govitecan treatment of patients with triple-negative breast cancer: multicenter insights曲拉妥珠单抗（sacituzumab govitecan）治疗三阴性乳腺癌患者的预用药及粒细胞集落刺激因子（G-CSF）应用策略：多中心见解
errSupportive Care in Cancer
IF3
err2025-09-28
err0
errOAAI
errMałgorzata Pieniążek; Anna Polakiewicz-Gilowska; Marcin Kubeczko; Manuela Las-Jankowska; Renata Pacholczak-Madej; Paulina Kilian-Van Miegem; Marek Ziobro; Aleksandra Łacko; Michał Jarząb; Miroslawa Püsküllüoğlu
err分享
err收藏
Baseline hemoglobin and neutrophil-to-lymphocyte ratio as prognostic biomarkers in patients with metastatic triple negative breast cancer treated with sacituzumab govitecan in second line and beyond: a real-world analysis基线血红蛋白和嗜中性粒细胞与淋巴细胞比值作为接受sacituzumab govitecan治疗的转移性三阴性乳腺癌患者（二线及以上治疗）的预后生物标志物：一项真实世界分析
errBreast Cancer Research and Treatment
IF3
err2025-09-27
err0
errOAAI
errMałgorzata Pieniążek; Anna Polakiewicz-Gilowska; Manuela Las-Jankowska; Jakub Wronowicz; Michał Jarząb; Aleksandra Łacko; Mirosława Püsküllüoğlu
err分享
err收藏
Weight change and BMI are not prognostic markers of survival outcomes in sacituzumab govitecan therapy for mTNBC in the Polish female cohort体重变化和BMI不是sacituzumab govitecan疗法在波兰女性队列中治疗mTNBC的生存结局的预后标志物
errTherapeutic Advances in Medical Oncology
IF4.2
err2025-08-19
err0
errOAAI
errMałgorzata Pienia̧żek; Anna Polakiewicz-Gilowska; Manuela Las-Jankowska; Jakub Wronowicz; Michał Jarza̧b; Aleksandra Łacko; Marek Ziobro; Mirosława Püsküllüoǧlu
err分享
err收藏
Impact of Pembrolizumab Addition on the Predictive Value of Metabolic Activity for Pathologic Complete Response in Breast Cancer帕博利珠单抗添加对代谢活性预测乳腺癌病理完全缓解价值的影响
errBREAST
IF7.9
err2025-02-01
err0
errOAAI
errKubeczko, M.; d'Amico, A.; Chrabanski, O.; Polakiewicz-Gilowska, A.; Swiderska, K.; Lesniak, A.; Mianowska-Malec, M.; Lanoszka, B.; Chomik, K.; Grandys, B.; Lisovska, N.; Handkiewicz-Junak, D.; Chmielik, E.; Jarzab, M.
err分享
err收藏
Efficacy of radiotherapy for bone metastasis in breast cancer patients treated with cyclin-dependent kinase 4/6 inhibitors
errRADIOTHERAPY AND ONCOLOGY
IF5.3
err2025-01-01
err0
errOAAI
errKubeczko, Marcin; Gabrys, Dorota; Rembak-Szynkiewicz, Justyna; Graupner, Donata; Polakiewicz-Gilowska, Anna; Jarzab, Michal
err分享
err收藏
The role of FDG PET assessment in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 inhibitors in the second-line setting
errFRONTIERS IN ONCOLOGY
IF3.3
err2024-12-03
err0
errOAAI
errKubeczko, Marcin; Polakiewicz-Gilowska, Anna; D'Amico, Andrea; Chrabanski, Olgierd; Swiderska, Katarzyna; Chmielik, Ewa; Blamek, Slawomir; Handkiewicz-Junak, Daria; Jarzab, Michal
err分享
err收藏
Sternotomy and extracorporal circulation for fulminant Budd-Chiari syndrome due to leiomyosarcoma of the inferior vena cava
errCARDIO-ONCOLOGY
IF3.2
err2024-11-25
err0
errOAAI
errWiewiora, Maciej; Wiewiora, Hanna; Chmielik, Ewa; Jarzab, Michal; Grynkiewicz, Michael; Kubeczko, Marcin
err分享
err收藏
Sacituzumab Govitecan for Second and Subsequent Line Palliative Treatment of Patients with Triple-Negative Breast Cancer: A Polish Real-World Multicenter Cohort StudySacituzumab Govitecan用于三阴性乳腺癌患者的二线和后续姑息治疗: 一项波兰真实世界多中心队列研究
errONCOLOGY AND THERAPY
IF3.2
err2024-09-27
err0
errOAAI
errPuskulluoglu, Miroslawa; Pieniazek, Malgorzata; Las-Jankowska, Manuela; Streb, Joanna; Ziobro, Marek; Pacholczak-Madej, Renata; Kilian-Van Miegem, Paulina; Rudzinska, Agnieszka; Grela-Wojewoda, Aleksandra; Lacko, Aleksandra; Jarzab, Michal; Polakiewicz-Gilowska, Anna
err分享
err收藏
Locoregional Radiotherapy in Patients with Advanced Breast Cancer Treated with Cyclin-Dependent Kinase 4/6 Inhibitors Based on Real-World Data基于真实世界数据的细胞周期蛋白依赖性激酶4/6抑制剂治疗晚期乳腺癌患者的局部放疗
errPHARMACEUTICALS
IF4.8
err2024-07-11
err0
errOAAI
errKubeczko, Marcin; Gabrys, Dorota; Polakiewicz-Gilowska, Anna; Bobek-Billewicz, Barbara; Jarzab, Michal
err分享
err收藏
Tailoring advanced breast cancer treatment after cyclin-dependent kinase 4/6 inhibitors progression - real-world data analysis
errFRONTIERS IN ONCOLOGY
IF3.3
err2024-06-07
err0
errOAAI
errKubeczko, Marcin; Polakiewicz-Gilowska, Anna; Swiderska, Katarzyna; Lesniak, Aleksandra; Mianowska-Malec, Marta; Lanoszka, Barbarba; Chomik, Konstanty; Grandys, Barbara; Lisovska, Natalya; Bobek-Billewicz, Barbara; Chmielik, Ewa; Jarzab, Michal
err分享
err收藏
Cyclin-dependent Kinase 4/6 Inhibitors Combined with Radiotherapy in the Management of Brain Metastases in HR-positive/HER2-negative Breast Cancer Patients
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errKubeczko, Marcin; Gabrys, Dorota; Polakiewicz-Gilowska, Anna; Krzywon, Aleksandra; Graupner, Donata; Lanoszka, Barbara; Mianowska-Malec, Marta; Lesniak, Aleksandra; Swiderska, Katarzyna; Chomik, Konstanty; Grandys, Barbara; Jarzab, Michal
err分享
err收藏
Safety and feasibility of CDK4/6 inhibitors treatment combined with radiotherapy in patients with HR-positive/HER2-negative breast cancer. A systematic review and meta-analysis (vol 187, 109839, 2023)
errRADIOTHERAPY AND ONCOLOGY
IF5.3
err2024-05-01
err0
errOAAI
errKubeczko, Marcin; Jarzab, Michal; Gabrys, Dorota; Krzywon, Aleksandra; Cortez, Alexander J.; Xu, Amy J.
err分享
err收藏
Moderate adverse events and regional differ- ences in CDK4/6 inhibitor treatment combined with palliative radiotherapy
errRADIOTHERAPY AND ONCOLOGY
IF5.3
err2023-11-01
err0
PREAI
errKubeczko, Marcin; Jarzab, Michal; Gabrys, Dorota; Krzywon, Aleksandra; Cortez, Alexander J.; Xu, Amy J.
err分享
err收藏
The effectiveness of a CBT-based mobile application for the mental state of women with breast cancer
errANNALS OF ONCOLOGY
IF65.4
err2023-10-01
err0
errOAAI
errHaneczok, M.; Wojtyna, E.; Jarzab, M.; Matkowski, R.; Syska-Bielak, A.; Kolodziejczyk, A.; Pawelczak-Szastok, M.; Kurasz, Z.; Krzyowski, M.; Ostrowski, M.
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
J
Jan Lubiński
H 指数: 128 · 论文数: 1.3K
F
Fátima Cardoso
H 指数: 103 · 论文数: 823
A
Aleix Prat
H 指数: 92 · 论文数: 1.3K
C
Carlos H. Barrios
H 指数: 86 · 论文数: 512
J
Jens Huober
H 指数: 79 · 论文数: 904
查看更多